Nodexus: William Rhodes

Nodexus, a company specializing in automated benchtop single-cell characterization and microfluidic isolation technologies, has named William Rhodes as executive chairman of the board of directors. Rhodes has served as an independent director since 2021 and was previously an advisor to the company. Rhodes spent 16 years at Becton Dickinson, including as senior VP of corporate strategy and development and worldwide president of BD Biosciences. He was also responsible for creating BD Ventures, the venture capital arm of BD. Prior to BD, he held senior positions at Johnson & Johnson and Pfizer. Rhodes holds a BS degree from Cornell University and a master's degree in international business from Seton Hall University.